CTI BIOPHARMA CORP 4
4 · CTI BIOPHARMA CORP · Filed May 2, 2017
Insider Transaction Report
Form 4
NUDELMAN PHILLIP M PHD
Director
Transactions
- Exercise/Conversion
Common Stock
2017-04-29+39,698→ 73,129 total - Exercise/Conversion
Restricted Stock Unit
2017-04-29−39,698→ 0 total→ Common Stock (39,698 underlying)
Footnotes (3)
- [F1]CTIC completed a 1-for-10 reverse stock split in January 2017. All share amounts reported in this Form 4 have been retroactively adjusted to reflect this stock split.
- [F2]Each restricted stock unit represents the right to receive, at settlement, one share of CTIC common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
- [F3]This restricted stock unit was granted on April 29, 2016 and vested on April 29, 2017.